Company / PP&E per Share
Cogent Biosciences, Inc. PP&E per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.04
FY2025
5-year range
$0.04 / $0.13
FY2021-FY2025
Trend
-32.0%
vs FY2024
Sector context
#126 of 193
Health Care
What the data says
At $0.04, Cogent Biosciences, Inc.'s pp&e per share ranks #126 of 193 in the Health Care sector. PP&E per Share has declined for 3 consecutive years, from $0.13 in FY2022 to $0.04 in FY2025.
Based on SEC 10-K filings.
0.04 in FY2025 with a 5-year CAGR of +28.5%.
Declined from $0.10 to $0.04 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -31.6%
- 5-Year CAGR
- +28.5%
- 10-Year CAGR
- -
Sector benchmark
#126 of 193 in Health CareTop 65% of 193This company $0.04 Sector average $18.71
▼
-99.8% below sector average
Key checks
Key Insights
- Cogent Biosciences, Inc.'s pp&e per share has declined for 3 consecutive years.
- In FY2025, pp&e per share decreased 32.0% year-over-year.
- Ranks #126 out of 193 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.04 | -32.0% |
| FY2024 | $0.06 | -40.6% |
| FY2023 | $0.10 | -20.9% |
| FY2022 | $0.13 | +200.8% |
| FY2021 | $0.04 | +264.3% |
| FY2020 | $0.01 | -95.1% |
| FY2019 | $0.24 | +87.4% |
| FY2018 | $0.13 | -67.6% |
| FY2017 | $0.40 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026